Analysis of Clinical Efficacy and Influencing Factors of Nerve Growth Factor (NGF) Treatment for Sudden Sensorineural Hearing Loss

医学 纯音测听 听觉脑干反应 测听 临床疗效 回顾性队列研究 脑干听觉诱发电位 听力损失 脑干 外科 内科学 听力学
作者
Zhengrong Liang,Minqian Gao,Haiying Jia,Wenjing Han,Yiqing Zheng,Yunfeng Zhao,Haidi Yang
出处
期刊:Ear, nose, & throat journal [SAGE]
被引量:3
标识
DOI:10.1177/01455613231181711
摘要

Objective: This study aims to examine the clinical efficacy and prognostic factors associated with nerve growth factor (NGF) treatment for sudden sensorineural hearing loss (SSHL). Materials and methods: A retrospective analysis was conducted on the clinical data of 101 patients with moderate or more severe SSHL who underwent secondary treatment at Sun Yat-sen Memorial Hospital of Sun Yat-sen University between January 2019 and July 2020. Prior to treatment, all patients were assessed using Pure Tone Audiometry (PTA), auditory brainstem response, otoacoustic emission, temporal bone computed tomography, or inner ear magnetic resonance imaging. Fifty-seven patients received conventional systemic treatment and served as the control group, while 44 patients received NGF in conjunction with conventional systemic treatment, forming the experimental group. PTA results were compared between the two groups before treatment and at 1 week, 2 weeks, and 1 month post-treatment. Additionally, the impact of age, sex, affected side, hypertension, and other factors on patient prognosis was analyzed. Results: Both groups demonstrated significant PTA improvements following treatment, with a statistically significant difference (P < .05). The hearing recovery effective rate in the control group was 42.1%, while that of the experimental group reached 70.5%, with a statistically significant difference between the groups (P < .05). Most patients experienced notable hearing improvements 1 week after treatment, with some patients still showing progress 2 weeks post-treatment. Multifactor analysis revealed that hypertension and onset days were associated with treatment outcomes. Conclusion: Secondary treatment remains clinically significant for patients with SSHL who have not achieved a satisfactory response or show no clear improvement following initial treatment. The presence of hypertension and delayed treatment are negative factors related to treatment efficacy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
bkagyin应助可靠的豌豆采纳,获得10
3秒前
ma526998发布了新的文献求助150
3秒前
汉堡包应助Sou采纳,获得30
4秒前
5秒前
部川苦茶发布了新的文献求助10
5秒前
5秒前
隐形曼青应助yjmsnh采纳,获得30
5秒前
6秒前
土豪的从凝完成签到,获得积分10
9秒前
希望天下0贩的0应助馨橣采纳,获得10
10秒前
Zoeytam完成签到,获得积分10
11秒前
透视眼完成签到 ,获得积分10
13秒前
研友_VZG7GZ应助大喜采纳,获得50
13秒前
tutu完成签到,获得积分10
14秒前
自由灵枫发布了新的文献求助10
15秒前
17秒前
梁梁梁完成签到,获得积分10
18秒前
雨下完成签到 ,获得积分10
18秒前
无敌小炣爱完成签到,获得积分10
20秒前
Orange应助热心市民小张采纳,获得10
20秒前
Cashwa完成签到,获得积分10
22秒前
22秒前
沐秋发布了新的文献求助10
23秒前
kang发布了新的文献求助10
23秒前
河河发布了新的文献求助10
23秒前
部川苦茶发布了新的文献求助10
24秒前
自由灵枫完成签到,获得积分10
24秒前
25秒前
animenz完成签到,获得积分10
26秒前
28秒前
二连完成签到,获得积分10
29秒前
orixero应助科研通管家采纳,获得10
30秒前
领导范儿应助科研通管家采纳,获得10
30秒前
Ava应助科研通管家采纳,获得10
30秒前
大模型应助科研通管家采纳,获得10
30秒前
科研通AI2S应助科研通管家采纳,获得10
30秒前
30秒前
30秒前
30秒前
汉堡包应助科研通管家采纳,获得10
30秒前
高分求助中
Earth System Geophysics 1000
Studies on the inheritance of some characters in rice Oryza sativa L 600
Medicina di laboratorio. Logica e patologia clinica 600
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
Language injustice and social equity in EMI policies in China 500
mTOR signalling in RPGR-associated Retinitis Pigmentosa 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3206745
求助须知:如何正确求助?哪些是违规求助? 2856198
关于积分的说明 8102939
捐赠科研通 2521287
什么是DOI,文献DOI怎么找? 1354335
科研通“疑难数据库(出版商)”最低求助积分说明 642012
邀请新用户注册赠送积分活动 613207